Adcendo (private company)

See something wrong or missing? Let us know
Offices:Copenhagen
Business model:B2B

Adcendo is a biotech company from Denmark developing novel antibody-drug conjugates (ADCs) for treatment of cancers

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 61.8M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Adcendo

Name Criteria
Denmark Galecto Biotech
73%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • At least one other investor: Ysios Capital
  • Total raised in a similar range: 10M+ USD
Ireland SynOx Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Ireland Priothera Limited
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark Draupnir Bio
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Sweden Aprea Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
France CorWave
60%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • At least one other investor: Ysios Capital
  • Total raised in a similar range: 10M+ USD
Top